Goldman Sachs led a USD100m Series C for Jushuitan, a Chinese SaaS platform backed by Sequoia China, with participation from CICC Capital and Blue Lake Capital. Read more… Read More
General Atlantic has exited Brazil-based educational software company Arco Platform via a secondary share offering of 5,563,203 Class A common shares at USD47.70 apiece. Read more… Read More
Riverstone has agreed to acquire 80% of two solar power plants in Mexico from Spain-based developer Opdenergy and to form Vera Renovables, a joint venture focused on the development of new renewable energy projects. Read more… Read More
Enterprise Investors has exited its 34.4% stake in Lithuania-based tour operator Novaturas for EUR4.9m (approximately USD5.5m) via a series of secondary transactions. Read more… Read More
SoftBank led a BRL120m (approximately USD22m) Series B for Brazil-based data company Cortex, with participation from Redpoint eventures and Endeavor Catalyst. Read more… Read More
Facebook and PayPal have invested an undisclosed amount in Indonesia-based ridesharing company Gojek as part of its ongoing Series F, along with existing investors Google and Tencent, reportedly bringing the funds raised to date to USD3b. Read more… Read More
ChrysCapital has acquired an additional 3% stake in India-based pharmaceutical company Intas for USD132m, providing an exit for Capital International. ChrysCapital originally invested in Intas in 2006, and the current investment brings its stake in the company to 6%. Read more… Read More
Blue Like an Orange Sustainable Capital has reached a USD200m+ final close for its first Latin America fund. The fund has a co-financing agreement with IDB Invest and counts over 25 limited partners, including AXA, HSBC, CNP Assurances, BNP Paribas Cardif, SG Insurance, MACSF, and several family offices. Read More
Sequoia Capital India and Hana Ventures led a USD26m Series A for Beam, a Singapore-based micro-mobility startup that operates e-scooters. Read more… Read More
Hillhouse Capital led a USD160m Series B for China-based biopharmaceutical company Genor Biopharma, with participation from Temasek Holdings, Haitong Capital, Cavenham PE, and CR-CP Life Science Fund, a joint venture between China Resources Group and Thailand’s Charoen Pokphand Group. Read more… Read More
(default archive template)